The Johnson & Johnson Covid-19 vaccine will take a pause from South Africa’s inoculation rollout plans. Health Minister Zweli Mkhize made the announcement of the temporary suspension of the vaccine after US health authorities called for a pause to the administering of the vaccine at home. It was in the wake of six recipients in America developing a rare disorder involving blood clots. The recipients were all women between the ages of 18 and 48. In South Africa, almost 290 000 healthcare workers have received the J&J vaccine.

Guest: Ministerial Advisory Committee(MAC) Member on Covid-19, Professor Ian Sanne